The Exercise Mimetic Compound Researchers Are Watching for Fat Loss and Endurance

Imagine if you could gain all the benefits of going for a long run… without ever leaving your couch.

It doesn't sound like science. It is science.

Metabolic researchers are experimenting with a variety of aerobic exercise mimetic compounds that flip the same fat burning and energy-producing "switches" in your body that exercise does.

And there's one aerobic exercise mimetic compound that's the most promising — and heavily scrutinized — in labs right now.

Its name? Slu pp 332.

Early research is promising. Several high-profile studies have been conducted.

SLU-PP-332 is considered one of the most well-researched aerobic exercise mimetic compounds in its class. Led by Professor Thomas Burris from the University of Florida, researchers found that mice treated with the compound experienced positive adaptations as if they had gone through endurance training — without actually doing any.

If you want to understand how these things work and what's on the horizon. This is one you should know.

What You're Going To Learn:

  1. What is an Aerobic Exercise Mimetic Compound?

  2. How Does SLU-PP-332 Work?

  3. How Does SLU-PP-332 Affect Fat Loss?

  4. How Does SLU-PP-332 Impact Endurance?

  5. Who Stands To Gain The Most From Research Into Compounds Like SLU-PP-332?

What Is an Aerobic Exercise Mimetic Compound?

An aerobic exercise mimetic compound is a pharmacological compound that elicits a response in the human body that closely mimics endurance exercise — at the cellular level.

When you go for a long run your body does a few things:

-       It starts burning fat for fuel.

-       Your mitochondria increases activity.

-       Your muscle fibres change slightly toward oxidative types.

-       Your resting energy expenditure increases.

That's the exercise equivalent of flipping several "fat burning" switches in your body.

An aerobic exercise mimetic compound works by activating those same biological pathways without you having to actually exercise.

This concept isn't new. But never before have we seen an aerobic exercise mimetic compound with this level of promising scientific backing.

Over the years several different aerobic exercise mimetic compounds have come up in scientific journals. But most had limited impact in practice — or worse, were linked to severe safety concerns.

SLU-PP-332 is different.

How Does SLU-PP-332 Work?

TL;DR: SLU-PP-332 targets your body's estrogen-related receptors (ERRs).

Humans have 3 types of ERRs:

-       ERRα

-       ERRβ

-       ERRγ

These aren't your typical estrogen receptors. Technically, they're considered "orphan" receptors. They work inside of your skeletal muscles, heart, and brown fat cells to control how energy is produced, stored, and utilised when your body is placed under stress — like during endurance exercise.

When you exercise, your ERRs naturally become activated.

SLU-PP-332 mimics that activation by binding to each receptor (but binds most tightly to ERRα). When they become activated, dozens of exercise responsive genes are turned on, leading to:

-       Increased mitochondrial function and cellular respiration

-       Enhanced fatty acid burning

-       Conversion of muscle fibres to more oxidative ("endurance") type

-       Increased resting energy expenditure

Essentially, it's telling your muscles to behave as though you're in the middle of a tough workout.

Cool, right?

How Does SLU-PP-332 Impact Fat Loss?

Here's where it gets exciting.

Researchers published a study in the Journal of Pharmacology and Experimental Therapeutics where they treated diet induced obese mice (as well as obese mice predisposed to obesity from birth) with SLU-PP-332 twice daily for 28 days. They experienced boosted fatty acid oxidation, increased resting energy expenditure, and significantly less fat mass accumulation. All without changing their diet or exercise habits.

Over 43% of adults were overweight in 2022. That's more than double the percentage of adults in 1990. Researchers are working on solutions as fast as they can — and aerobic exercise mimetic compounds like SLU-PP-332 are starting to look really attractive as a result.

SLU-PP-332 is different from traditional weight-loss drugs like Ozempic and Mounjaro because:

It has no effect on hunger or cravings. Ozempic and Mounjaro belong to a class of drugs known as GLP-1 drugs which work by curbing your appetite. But SLU-PP-332 works by changing the way muscles process and utilise energy. Many researchers believe the two methods could actually be combined in the future. You take the GLP-1 drug to reduce caloric intake. And you take the aerobic exercise mimetic to prevent muscle loss during that weight loss.

Preserving muscle tissue during weight loss is one of the biggest problems with traditional weight-loss drugs. Something like SLU-PP-332 could help solve that.

How Does SLU-PP-332 Impact Endurance?

The weight loss data is intriguing. But the impact SLU-PP-332 has on endurance is just as notable.

Researchers discovered that when they activated ERRs with SLU-PP-332, mice saw up to a 30% increase in endurance capacity out of nowhere. Mice ran longer and farther than their untreated counterparts without any physical training. Why?

Those same increases in type IIa oxidative skeletal muscle fibres you see with endurance training.

SLU-PP-332 is causing those same changes without the training stimulus.

All of which means…

If you're unable to train (due to aging, illness, or disease) you may be able to elicit some endurance-related metabolic benefits otherwise lost to you. That's huge. If it pans out in human trials. This could be a game changer for certain people who can't burn fat and calories the traditional way.

Who Stands To Gain The Most From Research Into Compounds Like SLU-PP-332?

Here's the kicker.

SLU-PP-332 and other aerobic exercise mimetic compounds aren't really being discussed in the context of athletics. Sure, more endurance capacity and muscle preservation would be incredible for anyone looking to build a fitness routine.

The biggest discussion around these compounds is centered around illness. Muscle degeneration due to ageing — known as sarcopenia — is something Professor Burris and his colleagues are especially focused on. Other areas of interest include:

-       Anyone on weight-loss drugs that are flushing out muscle mass

-       Seniors that aren't able to exercise due to injury or illness

-       Type 2 diabetes and fatty liver disease patients

-       People suffering from inflammatory myopathy or muscular dystrophy

Bonus info:

It's non-hormonal. Really. SLU-PP-332 doesn't suppress any natural hormones your body produces. In lab trials there were no significant adverse effects. But to be clear: there is no long-term human research confirming this compound is safe. Not yet. It will likely be years before SLU-PP-332 ever becomes available to the public. It's still in the animal treatment stage and researchers at UF Health are working to begin human clinical trials.

Conclusion

There you have it.

SLU-PP-332 is the aerobic exercise mimetic compound most talked about in metabolic circles. As a compound that targets ERRs (the same "energy" receptors in your body activated during endurance exercise), it successfully produced positive benefits in lab mice:

-       Increased fat burning

-       Increased energy expenditure

-       Reduced fat mass gain

-       Improved muscle fibre composition

-       Increased endurance capacity

Human research hasn't started. It's not an available treatment. But if there's an interest in fat loss research, exercise science, or just metabolic health in general. Keep an eye on SLU-PP-332.

‍ ‍

Related:

Previous
Previous

Preparing Men for Conception: A Comprehensive Approach and Recommendations

Next
Next

Accountability, Form, and Progress: The Hidden Value of Professional Fitness Guidance